A Meta-analytic Review of Non-specific Effects in Randomized Controlled Trials of Cognitive Remediation for Schizophrenia

Psychiatric Quarterly

Volumn 87, Issue 1, 2016, Pages 57-62

  Radhakrishnan, Rajiv ^a   Kiluk, Brian D ^a   Tsai, Jack ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c VA New England Mental Illness and Clinical Center (MIRECC)   (United States)

Author keywords

Cognitive remediation; Placebo; Randomized controlled trial; Schizophrenia

Indexed keywords

ARTICLE; COGNITION; COGNITIVE REMEDIATION THERAPY; EFFECT SIZE; HUMAN; INTELLIGENCE QUOTIENT; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SCHIZOPHRENIA; STRESS MANAGEMENT; TASK PERFORMANCE; TREATMENT DURATION; COGNITIVE THERAPY; CONTROL GROUP; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY;

COGNITION; COGNITIVE THERAPY; CONTROL GROUPS; HUMANS; NEUROPSYCHOLOGICAL TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84957427827     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-015-9362-6     Document Type: Article

References (19)

1. Armitage P. The role of randomization in clinical trials. Statistics in Medicine. 1(4):345–52, 1982.
2. Pilla Reddy V, Kozielska M, Johnson M, Suleiman AA, Vermeulen A, Liu J, et al. Modelling and simulation of the Positive and Negative Syndrome Scale (PANSS) time course and dropout hazard in placebo arms of schizophrenia clinical trials. Clinical Pharmacokinetics. 51(4):261–75, 2012. doi:10.2165/11598460-000000000-00000.
3. Alphs L, Benedetti F, Fleischhacker WW, Kane JM. Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it? International Journal of Neuropsychopharmacology. 15:1–12, 2012. doi:10.1017/S1461145711001738.
4. Correll CU, Kishimoto T, Kane JM. Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives. Dialogues in Clinical Neuroscience. 13(2):155–172, 2011.
5. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. The American Journal of Psychiatry. 164(12):1791–1802, 2007. doi:10.1176/appi.ajp.2007.07060906.
6. Grynszpan O, Perbal S, Pelissolo A, Fossati P, Jouvent R, Dubal S, et al. Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study. Psychological Medicine. 41(1):163–173, 2011. doi:10.1017/S0033291710000607.
7. Tsai J, Stroup TS, Rosenheck RA. Housing arrangements among a national sample of adults with chronic schizophrenia living in the United States: A descriptive study. Journal of Community Psychology 39(1);76–88, 2011.
8. Wykes T, Huddy V. Cognitive remediation for schizophrenia: it is even more complicated. Current Opinion in Psychiatry. 22(2):161–167, 2009. doi:10.1097/YCO.0b013e328322fbf4.
9. Torrey EF: Surviving Schizophrenia: A Manual for Families, Consumers, and Providers. 4th edn. New York, Harper-Collins, 2001.
10. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. The American Journal of Psychiatry. 168(5):472–485, 2011. doi:10.1176/appi.ajp.2010.10060855.
11. Cahill J, Barkham M, Hardy G, Rees A, Shapiro DA, Stiles WB, et al. Outcomes of patients completing and not completing cognitive therapy for depression. The British Journal of Clinical Psychology. 42(Pt 2):133–143, 2003. doi:10.1348/014466503321903553.
12. Thalheimer W, Cook S. How to Calculate Effect Sizes From Published Research Articles: A Simplified Methodology. 2002.
13. Marín-Martínez F, Sánchez-Meca J. Weighting by inverse variance or by sample size in random-effects meta-analysis. Educational and Psychological Measurement. 70(1):56–73, 2010. doi:10.1177/0013164409344534.
14. Kontis D, Huddy V, Reeder C, Landau S, Wykes T. Effects of age and cognitive reserve on cognitive remediation therapy outcome in patients with schizophrenia. The American Journal of Geriatric Psychiatry. 2012. doi:10.1097/JGP.0b013e31824877d7.
15. McGurk SR, Mueser KT. Response to cognitive rehabilitation in older vs. younger persons with severe mental illness. American Journal of Psychiatric Rehabilitation. 11:90–105, 2008.
16. Reeder C, Newton E, Frangou S, Wykes T. Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophrenia Bulletin. 30(1):87–100, 2004.
17. Farreny A, Aguado J, Ochoa S, Huerta-Ramos E, Marsa F, Lopez-Carrilero R, et al. REPYFLEC cognitive remediation group training in schizophrenia: Looking for an integrative approach. Schizophrenia Research. 2012. doi:10.1016/j.schres.2012.08.035.
18. Bark N, Revheim N, Huq F, Khalderov V, Ganz ZW, Medalia A. The impact of cognitive remediation on psychiatric symptoms of schizophrenia. Schizophrenia Research. 63(3):229–235, 2003.
19. Vinogradov S, Fisher M, Nagarajan S. Cognitive training in schizophrenia: golden age or wild west? Biological Psychiatry. 73(10):935–937, 2013. doi:10.1016/j.biopsych.2013.03.015.